Endocrine response and resistance in breast cancer: a role for the transcription factor Fos. (Q54105272)

24 May 2018

title

Endocrine response and resistance in breast cancer: a role for the transcription factor Fos. (English)

1 reference

24 May 2018

author

Julia Gee

1

1 reference

24 May 2018

Sarah E. Pinder

5

object named as

S E Pinder

1 reference

24 May 2018

6

I O Ellis

1 reference

24 May 2018

P C Willsher

2

1 reference

24 May 2018

F S Kenny

3

1 reference

24 May 2018

J F Robertson

4

1 reference

24 May 2018

R I Nicholson

7

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

24 May 2018

International Journal of Cancer

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 May 2018

volume

84

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

54-61

1 reference

24 May 2018

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Cell cycle kinetic effects of tamoxifen on human breast cancer cells. Flow cytometric analyses of DNA content, BrdU labeling, Ki-67, PCNA, and statin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Heat-induced bFGF gene expression in the absence of heat shock element correlates with enhanced AP-1 binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Gene therapy for the treatment of metastatic breast cancer by in vivo transduction with breast-targeted retroviral vector expressing antisense c-fos RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Phenotype suppression: a postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-specific genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

A dominant negative to activation protein-1 (AP1) that abolishes DNA binding and inhibits oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Induction of apoptosis by c-Fos protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Oestrogen receptor: a stable phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Fibroblast growth factor receptors have different signaling and mitogenic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Selective modulation of protein kinase A and protein kinase C activities in epidermal growth factor (EGF)-stimulated MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

The antiestrogen tamoxifen induces c-fos and jun-B, but not c-jun or jun-D, protooncogenes in the rat uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Analysis of hormone receptors and proliferation fraction in fine-needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

The expression of c-fos protein in human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990219%2984%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-X

10.1002/(SICI)1097-0215(19990219)84:1<54::AID-IJC11>3.0.CO;2-X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

release_mutuu6wgbrghdclmg2oimi4kja

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mutuu6wgbrghdclmg2oimi4kja

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9988233

1 reference

24 May 2018